Pamela Williams
Psychosomatic Medicine · Passaic, NJNPI 1831312065
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 446 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,403 and has fallen 66.4% since, to $471 in 2025.
Across 446 payments — averaging $15.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$939
- AbbVie$845
- Teva Pharmaceuticals USA, Inc.$766
- Lundbeck LLC$568
- Johnson & Johnson$518
- plus $2K from 11 others
What the payments were for
- Food & beverage$6,691100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
Too few psychosomatic medicine providers in New Jerseyto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FanaptIloperidone | 19 | $29,003 |
| RisperdalRisperidone | 12 | $22,615 |
| TrintellixVortioxetine Hydrobromide | 13 | $6,877 |
| Aripiprazole | 47 | $3,460 |
| Aripiprazole OdtAripiprazole | 15 | $2,585 |
| Quetiapine Fumarate | 113 | $1,852 |
| Ziprasidone Hcl | 21 | $1,353 |
| Hydroxyzine Hcl | 70 | $1,190 |
| Lamotrigine | 122 | $1,151 |
| Risperidone | 51 | $1,047 |
| Oxcarbazepine | 14 | $823 |
| Benztropine Mesylate | 57 | $816 |
| Sertraline Hcl | 105 | $700 |
| Divalproex Sodium | 19 | $644 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 14 | $550 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Vanda Pharmaceuticals Inc.Fanapt | $129 | $29,00319 claims |
| Johnson & JohnsonRisperdal | $518 | $22,61512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few psychosomatic medicine providers in New Jerseyon file to place this against a meaningful peer group, so we don't.
Other psychosomatic medicine in Passaic
- Ashwini NeelgundMatawan$8K
- Frederick KahnParamus$2K
- Ayman RamzySkillman$974
- Jan ChrobokGillette$744
- Adriana PhanHackensack$455
- Thomas CampoCherry Hill$116
- Annamaria NucciCedar Grove$110
- Justin CapoteMontclair$101
- Nina SugarRidgewood$49
- Lawrence EisensteinRed Bank$15
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.